Evidence map›Paper›PMID 25703322›Full record

ArticleThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2015

Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network.

Allison L Agwu, Lana Lee, John A Fleishman, Cindy Voss, Baligh R Yehia, Keri N Althoff, Richard Rutstein, W Christopher Mathews, Ank Nijhawan, Richard D Moore and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Time to Engage Young People in HIV Cure Research.AIDS research and human retroviruses · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Allison L AgwuDivision of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: ageorg10@jhmi.edu.
Lana LeeDivision of General Pediatrics and Adolescent Medicine, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.
John A FleishmanCenter for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville, Maryland.
Cindy VossDivision of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Baligh R YehiaDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Keri N AlthoffDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Richard RutsteinDivision of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
W Christopher MathewsDepartment of Clinical Medicine, University of California San Diego Medical Center, San Diego, California.
Ank NijhawanDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas Texas.
Richard D MooreDivision of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Aditya H GaurDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee.
Kelly A GeboDivision of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Johns Hopkins University · USJohns Hopkins Medicine · USAgency for Healthcare Research and Quality · USChildren's Hospital of Philadelphia · USSt. Jude Children's Research Hospital · USThe University of Texas Southwestern Medical Center · USUniversity of California San Diego Medical Center · USUniversity of Pennsylvania · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Adolescent Health Training ProgramT32HD052459 · NICHD · JOHNS HOPKINS UNIVERSITY · PI MARIA E. TRENT · 2006 to 2026
$4.0M
Challenging and Expanding Paradigms of Aging with HIVK01AI093197 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ALTHOFF, KERI NICOLE · 2011 to 2015
$646k
HAART Initiation in Behaviorally HIV-Infected YouthK23AI084549 · NIAID · JOHNS HOPKINS UNIVERSITY · PI AGWU, ALLISON L · 2010 to 2013
$537k
Evaluating Patient Retention in HIV CareK23MH097647 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI YEHIA, BALIGH RAMZI · 2012 to 2013
$361k
NIAID NIH HHS K01 AI093197NIAID NIH HHS K23 AI084549NIAID NIH HHS P30 AI045008NIAID NIH HHS P30 AI094189NICHD NIH HHS T32 HD052459NIMH NIH HHS K23 MH097647PHS HHS 290-11-00007C
6 · The paper itself

Abstract

purposeIn the United States, 21 years is a critical age of legal and social transition, with changes in social programs such as public insurance coverage. Human immunodeficiency virus (HIV)-infected youth have lower adherence to care and medications and may be at risk of loss to follow-up (LTFU) at this benchmark age. We evaluated LTFU after the 22nd birthday for HIV-infected youth engaged in care. LTFU was defined as having no primary HIV visits in the year after the 22nd birthday.

methodsAll HIV-infected 21-year-olds engaged in care (2002-2011) at the HIV Research Network clinics were included. We assessed the proportion LTFU and used multivariable logistic regression to evaluate demographic and clinical characteristics associated with LTFU after the 22nd birthday. We compared LTFU at other age transitions during the adolescent/young adult years.

resultsSix hundred forty-seven 21-year-olds were engaged in care; 91 (19.8%) were LTFU in the year after turning 22 years. Receiving care at an adult versus pediatric HIV clinic (adjusted odds ratio [AOR], 2.91; 95% confidence interval [CI], 1.42-5.93), having fewer than four primary HIV visits/year (AOR, 2.72; 95% CI, 1.67-4.42), and antiretroviral therapy prescription (AOR, .50; 95% CI, .41-.60) were independently associated with LTFU. LTFU was prevalent at each age transition, with factors associated with LTFU similar to that identified for 21-year-olds.

conclusionsAlthough 19.8% of 21-year-olds at the HIV Research Network sites were LTFU after their 22nd birthday, significant proportions of youth of all ages were LTFU. Fewer than four primary HIV care visits/year, receiving care at adult clinics and not prescribed antiretroviral therapy, were associated with LTFU and may inform targeted interventions to reduce LTFU for these vulnerable patients.

Indexed as

AdolescentAge FactorsAgingAmbulatory CareAnalysis of VarianceAnti-HIV AgentsCohort StudiesFemaleFollow-Up StudiesHIV InfectionsHumansMaleMultivariate AnalysisNeeds AssessmentPatient Acceptance of Health CarePatient ComplianceAnti-HIV AgentsAdolescentsAttritionCareHIV Research NetworkLoss to follow-upYoung adultsYouth

Identifiers

PMID25703322
PMCPMC4378241
OpenAlexW2076150931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.